XSHE
300314
Market cap392mUSD
Jul 10, Last price
9.43CNY
1D
2.06%
1Q
-26.67%
Jan 2017
-55.64%
IPO
18.92%
Name
Ningbo David Medical Device Co Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Ningbo David Medical Device Co., Ltd. is a global enterprise dedicated to the innovation, production, and worldwide distribution of medical equipment. The company's primary focus lies in providing essential neonatal care devices, such as infant incubators, transport incubators, infant radiant warmers, and phototherapy units for neonatal bilirubin. They also supply infant resuscitators. Beyond these core offerings, Ningbo David Medical Device Co., Ltd. manufactures a diverse range of other medical apparatus. These include infusion pumps, transcutaneous jaundice detectors, infant T-piece resuscitators, air/oxygen blenders, low-pressure aspirators, infant oxygen hoods, far infrared heaters, and infant head-fixing units. All products are marketed under the "David" brand. Established in 1992, the company maintains its headquarters in Ningbo, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2022‑00 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||||
Revenues | ||||||||||||
Cost of revenue | ||||||||||||
Unusual Expense (Income) | ||||||||||||
NOPBT | ||||||||||||
NOPBT Margin | ||||||||||||
Operating Taxes | ||||||||||||
Tax Rate | ||||||||||||
NOPAT | ||||||||||||
Net income | ||||||||||||
Dividends | ||||||||||||
Dividend yield | ||||||||||||
Proceeds from repurchase of equity | ||||||||||||
BB yield | ||||||||||||
| Debt | ||||||||||||
Debt current | ||||||||||||
Long-term debt | ||||||||||||
Deferred revenue | ||||||||||||
Other long-term liabilities | ||||||||||||
Net debt | ||||||||||||
| Cash flow | ||||||||||||
Cash from operating activities | ||||||||||||
CAPEX | ||||||||||||
Cash from investing activities | ||||||||||||
Cash from financing activities | ||||||||||||
FCF | ||||||||||||
| Balance | ||||||||||||
Cash | ||||||||||||
Long term investments | ||||||||||||
Excess cash | ||||||||||||
Stockholders' equity | ||||||||||||
Invested Capital | ||||||||||||
ROIC | ||||||||||||
ROCE | ||||||||||||
| EV | ||||||||||||
Common stock shares outstanding | ||||||||||||
Price | ||||||||||||
Market cap | ||||||||||||
EV | ||||||||||||
EBITDA | ||||||||||||
EV/EBITDA | ||||||||||||
Interest | ||||||||||||
Interest/NOPBT | ||||||||||||